HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Crest Whitestrips Ad Comparison To Simply White Gets Mixed NAD Review

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble's recent TV ad humorously comparing Crest Whitestrips to Colgate Simply White makes an adequately supported superior whitening claim but "falsely denigrates" the Colgate-Palmolive product, the National Advertising Division of the Council for Better Business Bureaus concludes in a recently-released review

You may also be interested in...



P&G Comes Out Sparkling As Judge Dismisses Colgate Complaint

Colgate's failure to provide a consumer survey supporting its argument that ad claims for Procter & Gamble's Crest Whitestrips and Night Effects denigrate Colgate Simply White and Simply White Night appeared to resonate with a jury hearing Colgate-Palmolive v. Procter & Gamble

P&G Comes Out Sparkling As Judge Dismisses Colgate Complaint

Colgate's failure to provide a consumer survey supporting its argument that ad claims for Procter & Gamble's Crest Whitestrips and Night Effects denigrate Colgate Simply White and Simply White Night appeared to resonate with a jury hearing Colgate-Palmolive v. Procter & Gamble

NAD More “Hospitable” Than Courts To Denigration Complaints – Conference

Product denigration challenges resulting from comparative advertising are more likely to be successful through the National Advertising Division of the Council of Better Business Bureaus than in federal court, NAD Director Andrea Levine suggested

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011223

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel